These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11536046)

  • 1. Myc lacks E2F1's ability to suppress skin carcinogenesis.
    Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
    Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
    Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
    Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
    Pierce AM; Fisher SM; Conti CJ; Johnson DG
    Oncogene; 1998 Mar; 16(10):1267-76. PubMed ID: 9546428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
    Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
    Russell JL; Weaks RL; Berton TR; Johnson DG
    Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y; Zacksenhaus E
    Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis.
    Wang D; Russell J; Xu H; Johnson DG
    Mol Carcinog; 2001 Jun; 31(2):90-100. PubMed ID: 11429786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.
    Budunova IV; Kowalczyk D; Pérez P; Yao YJ; Jorcano JL; Slaga TJ
    Oncogene; 2003 May; 22(21):3279-87. PubMed ID: 12761498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct repression of the Mcl-1 promoter by E2F1.
    Croxton R; Ma Y; Song L; Haura EB; Cress WD
    Oncogene; 2002 Feb; 21(9):1359-69. PubMed ID: 11857079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proliferative and apoptotic activities of E2F1 in the mouse retina.
    Lin SC; Skapek SX; Papermaster DS; Hankin M; Lee EY
    Oncogene; 2001 Oct; 20(48):7073-84. PubMed ID: 11704831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
    Lindström MS; Wiman KG
    Oncogene; 2003 Aug; 22(32):4993-5005. PubMed ID: 12902982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.
    Elliott MJ; Dong YB; Yang H; McMasters KM
    Clin Cancer Res; 2001 Nov; 7(11):3590-7. PubMed ID: 11705881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omomyc expression in skin prevents Myc-induced papillomatosis.
    Soucek L; Nasi S; Evan GI
    Cell Death Differ; 2004 Sep; 11(9):1038-45. PubMed ID: 15143346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors.
    Schuldiner O; Benvenisty N
    Oncogene; 2001 Aug; 20(36):4984-94. PubMed ID: 11526483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation.
    Berton TR; Mitchell DL; Guo R; Johnson DG
    Oncogene; 2005 Apr; 24(15):2449-60. PubMed ID: 15735727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIF loss impairs Myc-induced lymphomagenesis.
    Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
    Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CIS.
    Agger K; Santoni-Rugiu E; Holmberg C; Karlström O; Helin K
    Oncogene; 2005 Jan; 24(5):780-9. PubMed ID: 15531911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.